Skip to content

Ligand Pharmaceuticals LGND FX Effect on Cash

FX Effect on Cash at other companies

Revvity logo
RevvityRVTY
-$7.63M-147%
Roivant Sciences logo
Roivant SciencesROIV
$1.32M
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1M-200%
ALN
Alnylam PharmaceuticalsALNY
-$7.06M-150%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$48M-173%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.6B+96.7%

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's FX effect on cash?
Ligand Pharmaceuticals (LGND) reported FX effect on cash of -$44K in Q1 2026.
How has Ligand Pharmaceuticals's FX effect on cash changed year-over-year?
Ligand Pharmaceuticals's FX effect on cash decreased by 104.2% year-over-year, from $1.06M to -$44K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.